Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets
| Image |  |
|---|---|
| Description | scientific article published on 15 October 2018 |
| Author/s |
author: Antonio Passaro |
| Publication date | October 15, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |